Rainer Krahl

Acute Myeloid Leukemia (AML): Different Treatment Strategies Versus a Common Standard Arm—Combined Prospective Analysis by the German AML Intergroup

Thomas Büchner, Richard F. Schlenk, Markus Schaich et al. · Journal of Clinical Oncology · 2012 · 133 citations

Azacitidine in patients with acute myeloid leukemia medically unfit for or resistant to chemotherapy: a multicenter phase I/II study

Haifa Kathrin Al‐Ali, Nadja Jaekel, Georg Maschmeyer et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2011 · 114 citations

Hematological Malignancy, Oncology, Health Sciences +12

The effect of prior exposure to imatinib on transplant-related mortality.

Michael W. Deininger, Michael Schleuning, H. Greinix et al. · PubMed · 2006 · 114 citations

High incidence of BCR-ABL kinase domain mutations and absence of mutations of the PDGFR and KIT activation loops in CML patients with secondary resistance to imatinib

Haifa Kathrin Al‐Ali, Michael C. Heinrich, Thoralf Lange et al. · The Hematology Journal · 2004 · 109 citations

Hematological Malignancy, Oncology, Engineering +11

Early related or unrelated haematopoietic cell transplantation results in higher overall survival and leukaemia-free survival compared with conventional chemotherapy in high-risk acute myeloid leukaemia patients in first complete remission

Nadežda Basara, Antina Schulze, Ulrich Wedding et al. · Leukemia · 2009 · 79 citations

Hematological Malignancy, Radiation Oncology, Conventional Chemotherapy +15